While it is generally believed that the avidity of the T cell antigen receptor (TCR) for self antigen/major histocompatibility complex (MHC) determines a thymocyte's fate, how the cell discriminates between a stimulus that causes positive selection (survival) and one that causes negative selection (death) is unknown. We have previously demonstrated that glucocorticoids are produced in the thymus, and that they antagonize deletion caused by TCR cross-linking. To examine the role of glucocorticoids during MHC-dependent selection, we examined thymocyte development in organ cultures in which corticosteroid biosynthesis was inhibited. Inhibition of glucocorticoid production in thymi from α/β-TCR transgenic mice resulted in the antigen- and MHC-specific loss of thymocytes that normally recognize self antigen/MHC with sufficient avidity to result in positive selection. Furthermore, inhibition of glucocorticoid production caused an increase in apoptosis only in CD+CD8+ thymocytes bearing transgenic TCRs that recognized self antigen/MHC. These results indicate that the balance of TCR and glucocorticoid receptor signaling influences the antigen-specific thymocyte development by allowing cells with low-to-moderate avidity for self antigen/MHC to survive.
Skip Nav Destination
Article navigation
2 June 1997
Brief Definitive Report|
June 02 1997
Thymus-derived Glucocorticoids Regulate Antigen-specific Positive Selection
Melanie S. Vacchio,
Melanie S. Vacchio
From the *Laboratory of Immunology, Division of Hematologic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20852; and ‡Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1152
Search for other works by this author on:
Jonathan D. Ashwell
Jonathan D. Ashwell
From the *Laboratory of Immunology, Division of Hematologic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20852; and ‡Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1152
Search for other works by this author on:
Melanie S. Vacchio
From the *Laboratory of Immunology, Division of Hematologic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20852; and ‡Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1152
Jonathan D. Ashwell
From the *Laboratory of Immunology, Division of Hematologic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20852; and ‡Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1152
Address correspondence to Melanie S. Vacchio, Food and Drug Administration, Center for Biologics Evaluation and Review, Suite 200N/HFM 538, 1401 Rockville Pike, Rockville, MD 20852-1448.
Received:
March 14 1997
Revision Received:
April 11 1997
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 185 (11): 2033–2038.
Article history
Received:
March 14 1997
Revision Received:
April 11 1997
Citation
Melanie S. Vacchio, Jonathan D. Ashwell; Thymus-derived Glucocorticoids Regulate Antigen-specific Positive Selection. J Exp Med 2 June 1997; 185 (11): 2033–2038. doi: https://doi.org/10.1084/jem.185.11.2033
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement